MedPath

SANDOZ VALSARTAN HCT

SANDOZ VALSARTAN HCT

Approved
DIN Number

02356732

Drug Class

Human

Market Date

Jan 27, 2011

Company
HC

Sandoz Canada, Inc.

Product Information

Detailed information about this Health Canada approved drug product, including dosage form, route of administration, and regulatory classification.

Product Details

Health Canada regulatory and product classification information

Regulatory Identifiers
DIN Number02356732
AIG Number0240204005
Classification & Schedule
C
Drug Class
Human
S
Schedule
Prescription
A
ATC Code
C09DA03 VALSARTAN AND DIURETICS
Product Specifications
Dosage FormTablet
Route of AdministrationOral
AHFS Classification40:28.20
Health Canada Classification

ACTIVE INGREDIENTS (2)

HYDROCHLOROTHIAZIDEActive
Strength: 25 MG
Monograph: HYDROCHLOROTHIAZIDE
VALSARTANActive
Strength: 320 MG
Monograph: VALSARTAN

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.